1-6 of 6
Yutaka Kobayashi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1 / FLT3 -ITD Genotypes in Patients with Acute Myeloid Leukemia

Atsushi Marumo, Satoshi Wakita, Kaoru Morita, Shinichi Kako, Takashi Toya, Yuho Najima, Noriko Doki, Junya Kanda, Junya Kuroda, Shin-Ichiro Mori, Atsushi Satake, Kensuke Usuki, Toshimitsu Ueki, Nobuhiko Uoshima, Yutaka Kobayashi, Eri Kawata, Kazutaka Nakayama, Yuhei Nagao, Katsuhiro Shono, Motoharu Shibusawa, Jiro Tadokoro, Masao Hagihara, Hitoji Uchiyama, Naoyuki Uchida, Yasushi Kubota, Shinya Kimura, Hisao Nagoshi, Tatsuo Ichinohe, Saiko Kurosawa, Sayuri Motomura, Hashimoto Akiko, Hideharu Muto, Eriko Sato, Masao Ogata, Kenjiro Mitsuhashi, Jun Ando, Haruko Tashiro, Masahiro Sakaguchi, Shunsuke Yui, Kunihito Arai, Tomoaki Kitano, Miho Miyata, Takahiro Fukuda, Yoshinobu Kanda, Hiroki Yamaguchi
Journal: Blood
Blood (2022) 140 (Supplement 1): 8914–8916.
https://doi.org/10.1182/blood-2022-158686
Published: 2022
Journal Articles

Interim Serum Soluble Interleukin-2 Receptor Levels Are Strongly Associated with Prognosis in Newly Diagnosis DLBCL Patients

Haruya Okamoto, MD, Akihiro Miyashita, MD, Hiroaki Nagata, MD, Yasuhiko Tsutsumi, MD PhD, Yuri Kamitsuji, MD PhD, Yutaka Kobayashi, MD PhD, Nobuhiko Uoshima, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4118.
https://doi.org/10.1182/blood-2019-122375
Published: 2019
Journal Articles

Prognostic Impact of Past History of Other Malignancies in Diffuse Large B Cell Lymphoma

Kazuna Tanba, MD, Yoshiaki Chinen, MDPhD, Hitoji Uchiyama, MD PhD, Nobuhiko Uoshima, MD PhD, Kazuho Shimura, MD PhD, Shin-ichi Fuchida, MD PhD, Miki Kiyota, MD PhD, Mitsushige Nakao, MD PhD, Yuji Shimura, MD PhD, Tsutomu Kobayashi, MD PhD, Shigeo Horiike, MD PhD, Katsuya Wada, MD PhD, Chihiro Shimazaki, MD PhD, Hiroto Kaneko, MD PhD, Yutaka Kobayashi, MD PhD, Masafumi Taniwaki, MD PhD, Junya Kuroda, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1570.
https://doi.org/10.1182/blood.V130.Suppl_1.1570.1570
Published: 2017
Journal Articles

The Kyoto Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Tsutomu Kobayashi, MD PhD, Junya Kuroda, MD PhD, Isao Yokota, PhD, Kazuna Tanba, MD, Tomohiko Taki, MD PhD, Takahiro Fujino, MD, Saeko Kuwahara, MD, Reiko Isa, MD, Junko Yamaguchi, MD, Eri Kawata, MD PhD, Teruaki Akaogi, MD, Hitoji Uchiyama, MD PhD, Hiroto Kaneko, MD, Nobuhiko Uoshima, MD PhD, Yutaka Kobayashi, MD PhD, Satoshi Teramukai, PhD, Masafumi Taniwaki
Journal: Blood
Blood (2015) 126 (23): 3877.
https://doi.org/10.1182/blood.V126.23.3877.3877
Published: 2015
Journal Articles

Comparison Of Treatment Results Using High-Dose MTX Plus High-Dose AraC and High-Dose MTX Plus CHOP Regimens For Primary Central Nervous System Lymphoma

Hitoji Uchiyama, MD, PhD, Miki Kiyota, MD, Kazuna Tanba, MD, Eri Kawata, MD, PhD, Teruaki Akaogi, MD, Yutaka Kobayashi, MD, PhD, Masafumi Taniwaki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5102.
https://doi.org/10.1182/blood.V122.21.5102.5102
Published: 2013
Journal Articles

The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph + leukemia activity of imatinib mesylate

Junya Kuroda, Shinya Kimura, Hidekazu Segawa, Yutaka Kobayashi, Toshikazu Yoshikawa, Yoshimasa Urasaki, Takanori Ueda, Fumio Enjo, Harukuni Tokuda, Oliver G. Ottmann, Taira Maekawa
Journal: Blood
Blood (2003) 102 (6): 2229–2235.
https://doi.org/10.1182/blood-2003-01-0305
Published: 2003